CSPC Pharmaceutical Group Limited
CSPCY | OTC
$4.07
+$0.13 (+3.30%)
Nov 2, 2026, 11:13 AM ET · Market open
Market Data
Market Cap $11.87B
Enterprise Value $60.83B
Beta 0.75
Average Volume 1.69K
Shares Outstanding (Diluted) 11.42B
Shares Change YoY -3.54%
Institutional Ownership N/A
Exchange OTC
ISIN US12591J2078
Price Performance
Price Change 1M -20.2%
Price Change 3M -4.9%
Price Change 6M -6.4%
Price Change YTD -5.6%
Price Change 1Y 4.9%
Price Change 3Y 15.0%
Price Change 5Y -1.0%
1M CAGR (ann.) -14.7%
1Y CAGR (ann.) 4.2%
5Y CAGR (ann.) 1.5%
All-Time CAGR 6.8%
Valuation
PE Ratio 42.38
Forward PE N/A
PEG Ratio 0.11
Forward PEG 0.13
PS Ratio 2.63
Forward PS 2.20
PB Ratio 2.09
P/FCF Ratio 6.64
P/Adj. FCF Ratio 6.70
P/OCF Ratio 22.77
EV/Sales 1.97
EV/EBIT 7.05
EV/EBITDA 6.09
EV/FCF 4.98
Earnings Yield 2.5%
FCF Yield 15.8%
Adj. FCF Yield 15.7%
Financial Health
Net Cash ¥17.95B
Total Debt ¥652.37M
Cash & Short-Term Investments ¥18.48B
Total Assets ¥56.01B
Current Ratio 2.14
Quick Ratio 1.93
Debt / Equity Ratio 0.02
Debt / EBITDA 0.07
Debt / FCF 0.05
OCF / Debt 21.13
Interest Coverage 289.44
Altman Z-Score 4.23
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 71.9%
Operating Profit Margin 27.9%
EBITDA Margin 32.4%
Net Profit Margin 23.7%
FCF Margin 39.6%
Adj. FCF Margin 39.2%
SBC / Revenue 0.4%
SBC Impact (per share) -0.9%
Returns
Return on Assets 13.1%
Return on Equity 20.7%
Return on Invested Capital 17.4%
Return on Capital Employed 20.7%
Return on Tangible Assets 13.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 11.8%
Revenue CAGR 5Y 29.9%
Revenue CAGR 10Y 24.6%
EPS CAGR 3Y 26.6%
EPS CAGR 5Y 42.7%
EPS CAGR 10Y 35.9%
FCF CAGR 3Y 63.3%
FCF CAGR 5Y 43.8%
FCF CAGR 10Y 33.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date May 27, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $1.14B
Revenue Growth Est (next Q) 330.1%
Fair Value Estimates
Graham Number $1.05
Graham Upside -73.3%
Lynch Fair Value $2.32
Lynch Upside -41.1%
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥13.78B
Free Cash Flow ¥12.21B
Adj. Free Cash Flow ¥12.1B
FCF Per Share $1.07
OCF Per Share $1.21
OCF/S Ratio 44.7%
Income Statement
Revenue ¥30.86B
Gross Profit ¥22.17B
Operating Income ¥8.62B
EBITDA ¥9.98B
Net Income ¥7.32B
EPS (Diluted) $0.65
Revenue / Employee $1.57M
Profit / Employee $371.68K
Employees 19,700
Dividends
Annual Dividend $0.17
Dividend Yield 4.31%
Payout Ratio 25.9%
FCF Payout Ratio 20.1%
Adj. FCF Payout Ratio 20.3%
Dividend Growth (YoY) 36.5%
Pay Frequency Semi-Annual
Ex-Dividend Date Oct 21, 2026
Add to Watchlist
Select watchlists to add or remove CSPCY